Bone morphogenetic proteins and bFGF exert opposing regulatory effects on PTHrP expression and inorganic pyrophosphate elaboration in immortalized murine endochondral hypertrophic chondrocytes (MCT cells)

Journal of Bone and Mineral Research

Volumn 13, Issue 6, 1998, Pages 931-941

  Terkeltaub, Robert A ^a,b   Johnson, Kristen ^a   Rohnow, David ^a   Goomer, Randy ^a   Burton, Doug ^a   Deftos, Leonard J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1BETA; NUCLEOTIDE PYROPHOSPHATASE; OSTEOGENIC PROTEIN 1; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PYROPHOSPHATE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CARTILAGE CELL; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; ENZYME ACTIVITY; ENZYME INHIBITION; HORMONE RESPONSE; MITOSIS INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; CHILD, PRESCHOOL; CHONDROCYTES; DIPHOSPHATES; DRUG ANTAGONISM; FIBROBLAST GROWTH FACTOR 2; HUMANS; MICE; PARATHYROID HORMONE; PARATHYROID HORMONE-RELATED PROTEIN; PHENOTYPE; PROTEIN BIOSYNTHESIS; PROTEINS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031781044     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.6.931     Document Type: Article

References (58)

1. Gerstenfeld LC, Shapiro FD 1996 Expression of bone-specific genes by hypertrophic chondrocytes: Implication of the complex functions of the hypertrophic chondrocyte during endochondral bone development. J Cell Biochem 62:1-9.
2. Cancedda R, Descalzi-Cancedda F, Castagnola P 1995 Chondrocyte differentiation. Int Rev Cytol 159:265-358.
3. Lefebvre V, Garofalo S, de Crombrugghe B 1995 Type X collagen gene expression in mouse chondrocytes immortalized by a temperature-sensitive simian virus 40 large tumor antigen. J Cell Biol 128:239-245.
4. Yang KH, Stewart AF 1996 Parathyroid hormone-related protein: The gene, its mRNA species, and protein products. In: Bilezikian JP, Raisz LG, Rodan GA (eds.) Principles of Bone Biology. Academic Press, New York, NY, U.S.A., pp. 347-362.
5. Loveys LS, Gelb D, Hurwitz SR, Puzas JE, Rosier RN 1993 Effects of parathyroid hormone-related peptide on chick growth plate chondrocytes. J Orthop Res 11:884-891.
6. Lee K, Lanske B, Karaplis AC, Deeds JD, Kohno H, Nissenson RA, Kronenberg HM, Segre GV 1996 Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology 137: 5109-5118.
7. Vortkamp A, Lee K, Lanske B, Segre GV, Kroneberg M, Tabin CJ 1996 Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273:613-622.
8. Amizuka N, Karaplis AC, Henderson JE, Warshawsky H, Lipman ML, Matsuki Y, Ejiri S, Tanaka M, Izumi N, Ozawa H, Goltzman D 1996 Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev Biol 175:166-176.
9. Amizuka N, Henderson JE, Hoshi K, Warshawsky H, Ozawa H, Goltzman D, Karaplis AC 1996 Programmed cell death of chondrocytes and aberrant chondrogenesis in mice homozygous for parathyroid hormone-related peptide gene deletion. Endocrinology 137:5055-5067.
10. Weir EC, Philbrick WM, Amling M, Neff LA, Baron R, Broadus AE 1996 Targeted overexpression of parathyroid hormone-related peptide causes chondrodysplasia and delayed endochondral bone formation. Dev Biol 93:10240-10245.
11. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VLJ, Kronenberg HM, Mulligan R 1994 Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8:277-289.
12. Henderson JE, Amizuka N, Warhawsky H, Biasotto D, Lanske BM, Goltzman D, Karaplis AC 1995 Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol Cell Biol 15:4064-4075.
13. Amling M, Neff L, Tanaka S, Inoue D, Kuida K, Weir E, Philbrick WM, Broadus AE, Baron R 1997 Bcl-2 lies down-stream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J Cell Biol 136:205-213.
14. Rosen V, Cox K, Hattersley G 1996 Bone morphogenetic proteins. In: Bilezikian JP, Raisz LG, Rodan GA (eds.) Principles of Bone Biology. Academic Press, New York, NY, U.S.A., pp. 661-671.
15. Reddi AH, Cunningham NS 1993 Initiation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res 8 (Suppl 2):S499-S502.
16. Rosen V, Nove J, Song JJ, Thies RS, Cox K, Wozney JM 1994 Responsiveness of clonal limb bud cell lines to Bone Morphogenetic Protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. J Bone Miner Res 9:1759-1768.
17. Hiraki Y, Inoue H, Shigeno C, Sanma Y, Bentz H, Rosen DM, Asada A, Suzuki F 1991 Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro. J Bone Miner Res 6:1373-1385.
18. Komaki M, Katagiri T, Suda T 1996 Bone morphogenetic protein-2 does not alter the differentiation pathway of committed progenitors of osteoblasts and chondroblasts. Cell Tissue Res 284:9-17.
19. Mayer H, Scutt AM, Ankenbauer T 1996 Subtle differences in the mitogenic effects of recombinant human bone morphogenetic proteins-2 to -7 on DNA synthesis on primary bone-forming cells and identification of BMP-2/4 receptor. Calcif Tissue Int 58:249-255.
20. Duprez D, Bell EJ, Richardson MK, Archer CW, Wolpert L, Brickell PM, Francis-West PH 1996 Overexpression of BMP-2 and BMP-4 alters the size and shape of developing skeletal elements in the chick limb. Mech Dev 57:145-157.
21. Sakano S, Murata Y, Miura T, Iwata H, Sato K, Matsui N, Seo H 1993 Collagen and alkaline phosphatase gene expression during bone morphogenetic protein (BMP)-induced cartilage and bone differentiation. Clin Orthop 292:337-344.
22. Boden SD, McCuaig K, Hair G, Racine M, Titus L, Wozney JM, Nanes MS 1996 Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. Endocrinology 137:3401-3407.
23. Carey DE, Liu X 1995 Expression of bone morphogenetic protein-6 messenger RNA in bovine growth plate chondrocytes of different size. J Bone Miner Res 10:401-405.
24. Grimsrud CD, Romano PR, DeSouza MJ, Reynolds PR, Puzas JE, Rosier RN, O'Keefe RJ 1997 BMP-6 commits chondrocytes to the hypertrophic phenotype. J Bone Miner Res 12 (Suppl 1):S161.
25. Houston B, Thorp BH, Burt DW 1994 Molecular cloning and expression of bone morphogenetic protein-7 in the chick epiphyseal growth plate J Mol Endocrinol 13:289-301.
26. Kato Y, Iwamoto M 1990 Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. J Biol Chem 265: 5903-5909.
27. Iwamoto M, Shimazu F, Nakashima K, Suzuki F, Kato Y 1991 Reduction in basic fibroblast growth factor receptor is coupled with terminal differentiation of chondrocytes. J Biol Chem 266:461-467.
28. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P 1996 Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-921.
29. Coffin JD, Florkiewicz RZ, Neumann J, Mort-Hopkins T, Dorn GW III, Lightfoot P, German R, Howles P, Kier A, O'Toole BA, Sasse J, Gonzalez AM, Baird A, Doeschman TC 1995 Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol Cell Biol 6:1861-1873.
30. Hurley MM, Florkiewicz RZ 1996 Fibroblast growth factor and vascular endothelial cell growth factor families. In: Bilezikian JP, Raisz LG, Rodan GA (eds.) Principles of Bone Biology. Academic Press, New York, NY, U.S.A., pp. 627-645.
31. Kirsch T, Nah HD, Shapiro IM, Pacifici M 1997 Regulated production of mineralization-competent matrix vesicles in hypertrophic chondrocytes. J Cell Biol 137:1149-1160.
32. Ryan LM, McCarty DJ 1997 Calcium pyrophosphate crystal deposition disease, pseudogout, and articular chondrocalcinosis. In: Koopman WJ (ed.) Arthritis and Allied Conditions, 13th Ed. Williams and Wilkins, Baltimore, MD, U.S.A., pp. 2103-2126.
33. Rosenthal AK, McCarty BA, Cheung HS, Ryan LM 1993 A comparison of the effect of transforming growth factor beta 1 on pyrophosphate elaboration from various articular tissues. Arthritis Rheum 36:539-542.
34. Oyajobi BO, Caswell AM, Russell RG 1994 Transforming growth factor beta increases ecto-nucleoside triphosphate pyrophosphatase activity of human bone-derived cells. J Bone Miner Res 9:99-109.
35. 3, parathyroid hormone, and dexamethasone. J Bone Miner Res 9:1259-1266.
36. Anderson HC 1988 Mechanisms of pathologic calcification. Rheum Dis Clin North Am 14:303-319.
37. Meyer JL 1984 Can biological calcification occur in the presence of pyrophosphate? Arch Biochem Biophys 231:1-8.
38. Meyer JL, Reddi AH 1985 Changes in pyrophosphatase activity during the de novo mineralization associated with cartilage and bone formation. Arch Biochem Biophys 242:532-539.
39. Jung A, Bisaz S, Fleisch H 1973 The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals. Calcif Tissue Res 11:269-280.
40. McGaughey C 1983 Binding of polyphosphates and phosphonates to hydroxyapatite, susbsequent hydrolysis, phosphate exchange and effects on demineralization, mineralization, and microcrystal aggregation. Caries Res 17:229-241.
41. Fleisch HA 1997 Bisphosphonates: Preclinical aspects and use in osteoporosis. Ann Med 29:55-62.
42. Lotz M, Rosen F, McCabe G, Quach J, Blanco F, Dudler J, Solan J, Goding J, Seegmiller JE, Terkeltaub R 1995 IL-1β suppresses TGFβ-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes. Proc Natl Acad Sci USA 92:10364-10368.
43. Ditmer LS, Burton DW, Deftos LJ 1996 Elimination of the carboxy-terminal sequences of parathyroid hormone-related 1-173 increases production and secretion of the truncated forms. Endocrinology 137:1608-1617.
44. Solan J, Deftos LJ, Goding JW, Terkeltaub RA 1996 Expression of the nucleoside Triphosphate pyrophosphohydrolase PC-1 is induced by basic fibroblast growth factor (bFGF) and modulated by activation of the protein kinase A and C pathways in osteoblast-like osteosarcoma cells. J Bone Miner Res 11:183-192.
45. Rosenthal AK, Henry LA 1996 Retinoic acid stimulates pyrophosphate elaboration by cartilage and chondrocytes. Calcif Tissue Int 59:128-133.
46. Loveridge N, Farquharson C, Hesketh JE, Jakowlew SB, Whitehead CC, Thorp BH 1993 The control of chondrocyte differentiation during endochondral bone growth in vivo: Changes in TGF-beta and the proto-oncogene c-myc. J Cell Sci 105:949-956.
47. D'Angelo M, Pacifici M 1997 Articular chondrocytes produce factors that inhibit maturation of sternal chondrocytes in serum-free agarose cultures: A TGF-β independent process. J Bone Miner Res 12:1368-1377.
48. Berry JL, Farquharson C, Whitehead CC, Mawer EB 1996 Growth plate chondrocyte vitamin D receptor number and affinity are reduced in avian tibial dyschondroplastic lesions. Bone 19:197-203.
49. Horan J, Dean DD, Kieswetter K, Schwartz Z, Boyan BD 1996 Evidence that interleukin-1, but not interleukin-6, affects costochondral chondrocyte proliferation, differentiation, and matrix synthesis through an autocrine pathway. J Bone Miner Res 11:1119-1129.
50. Vargas SJ, Naprta A, Glaccum M, Lee SK, Kalinowski J, Lorenzo JA 1996 Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor. J Bone Miner Res 11:1736-1744.
51. Rousseau F, Bonaventure J, Legeal-Mallet L, Pelet A, Rozet JM, Maroteaux P, Le Merrer M, Munnich A 1994 Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371:252-254.
52. Shiang R, Thompson LM, Zhy YZ, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ 1994 Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335-342.
53. Massague J 1996 TGFβ signaling: Receptors, transducers, and Mad proteins. Cell 85:947-950.
54. Yamashita H, Ten Dijke P, Heldin C-H, Miyazono K 1996 Bone morphogenetic protein receptors. Bone 19:569-574.
55. Zou H, Wieser R, Massague J, Niswander L 1997 Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage. Genes Dev 11:2191-2203.
56. Yamaji N, Celeste AJ, Thies RS, Song JJ, Bernier SM, Goltzman D, Lyons KM, Nove J, Rosen V, Wozney JM 1994 A mammalian serine/threonine kinase receptor specifically binds BMP-2 and BMP-4. Biochem Biophys Res Commun 205: 1944-1951.
57. Baker JC, Harland RM 1997 From receptor to nucleus: The Smad pathway. Curr Opin Genet Dev 7:467-473.
58. Hoodless Haerry T, Abdollah S, Stapleton M, O'Connor MB, Attisano L, Wrana JL 1996 MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85:489-500.